NRGN and Alzheimer disease: The accuracy of the Aβ1−42/1−40 ratio in differentiating patients with AD dementia from patients with aMCI due to AD was lower than that of Ng, with AUC 0.52, suggesting that CSF Ng levels have value in evaluating AD-related impairment stage.